Like me, you're probably on a lot of e-mailing lists. Like me, you probably signed up for some of them. This may have been an act of thoughtful deliberation and intelligent judgment, the natural culmination of an irresistible lifelong compulsion, a momentary whimsical impulse, or the unintended consequence of failing to uncheck that tiny box in the lower right-hand corner of your last online purchase. And, like me, you're probably on a number of e-mailing lists that you never signed up for, even in the remotest parallel universe: the fringe political parties for which you have not the smallest iota of sympathy; the nubile young women from far-away lands who want to share their intimate photos; the latest gadget for enlarging body parts that you, personally, certainly have no need of enlarging.
I'm sure that many of you receive regular e-mails from many of the same sources that I do: ISAKOS, Major League Baseball, the Internet Hamster Association of North America . okay, I'm not actually a member of that group, but there is such a website (http://www.ihana .us). However, unless you're the editor of a medical journal, you probably are not on all the e-mailing lists that I am, especially the ones that send out press releases in the hopes that their content will be disseminated around the globe. I'd like to think that these e-mailing lists have titles like Editors of Distinguished Medical Journals of the World, but from the content that they're pushing, some probably have titles like Desperate Editors of Pulpy Rags Who Will Print Almost Any Garbage That You Send Them. A recent sampling of my in-box included press releases touting an overlooked yet ridiculously simple cure for cancer, the shocking link between the Hadron supercollider and the Mayan Doomsday, favorite family recipes of dead Hollywood celebrities, and the latest tellall by the surviving grandniece of the infamous Al Capone. I swear I'm not making this up.
Publicity is a thriving enterprise, especially in the modern Internet era. As the editor of a medical journal, I am keenly aware that whatever appears in our pages will not only be read by specialists in orthopaedic sports medicine, but potentially reported to the public at-large in the lay press. Not surprisingly, that reportage may not always be accurate. 2, 8, 14 A 1995 study from Yale University 8 examined 116 news articles on the prevention and detection of breast cancer and mammography. Only 75 of these cited any particular research reports, and 40 of those contained one or more references that could not be traced to their original source. Ultimately, among 60 traceable citations, the authors found 42 inaccuracies in comparison to the related scientific publications. The types of misinformation described included misleading titles, treating speculation as fact, omitting qualifications to findings, and overgeneralizing results to populations not studied. Some of these errors could be traced to undocumented personal communications between the original author and the reporter; it could not be determined whether the mistake was the fault of the reporter or the result of the author appending supplemental information that had not been submitted for peer review. Interestingly, a survey of medical authors who had dealt with the media found that, although many had concerns about the way in which science was portrayed in general, only 3% felt that their own work had been incorrectly reported. 2, 12 Some inaccuracies may be traceable to the press releases put out by the journals themselves. 7, 14 A study that analyzed 127 press releases from 7 top general medical journals 14 found that the information provided was often incomplete: only 23% noted study limitations, 65% reported main effects using numbers, and 22% mentioned commercial funding of the research.
It seems unlikely that a press release can, on its own, create media interest in a journal article. In 2002, a paper in Preventive Medicine investigated the press coverage of 95 articles from 2 major medical journals, one that issues regular press releases and one that does not. 11 The author found that press releases predicted extensive news coverage mainly when the associated article was inherently newsworthy. Among the characteristics she analyzed for newsworthiness, the ones that actually correlated with more intense media coverage included epidemiological studies, articles with lifestyle implications, studies that stratified risk to particular population groups, and evidence that was either strongly supportive or contradictory to popular consensus. Notably, studies that reached ''negative,'' (ie, indefinite) conclusions were decidedly un-newsworthy.
A unique insight into what makes a journal article newsworthy was initiated in March of 1991 when the Journal of the American Medical Association (JAMA) published 2 different papers exploring a possible association between radiation exposure and the subsequent development of cancer. In the first study, the health status of white men who worked at the Oak Ridge National Laboratory, a nuclear research facility, between 1943 and 1972 was tracked through 1984. 13 The signal finding was that, although the overall mortality of this group was 26% lower than the general population, the death rate from leukemia was 63% higher than expected.
The pages immediately following this paper contained a similar study of deaths from leukemia and other malignancies in 107 US counties adjacent to nuclear power plants. 5 The mortality from each index county was compared with that of 2 or 3 matched control counties from the same region for the period 1950 to 1984. Although over 900,000 deaths from cancer occurred in the index counties during that time, the mortality rate for leukemia and 14 other cancers was no greater than in the 292 control counties. The authors concluded that there was no evidence for an increased risk of cancer among those living in the vicinity of the nuclear plants.
Seven months later, a new paper in JAMA reported the news coverage of these 2 publications, which decidedly favored the study that found an increased risk of leukemia at the Oak Ridge Laboratory over the one with negative findings. 6 Although the 2 studies had appeared side by side, only 10 of 19 related news stories mentioned both articles; the other 9 only discussed the study that had found a positive link between radiation exposure and leukemia. No news articles were found that focused solely on the negative report, and those that discussed both papers devoted considerably more space to the ''positive'' article. These findings were especially remarkable because the negative study was directly relevant to a much larger population group, the millions of people living near a nuclear facility, than the ''positive'' study, limited to white men who actually worked inside one. In this case, the journalistic mantra, ''If it bleeds, it leads,'' seems to have proven true.
The take-home lesson from this JAMA study is not that journalists prefer to report bad news, but simply that they prefer to report a story, a narrative with a strong message and novel information. 4 If anything, they would rather report a therapeutic breakthrough. 2, 7 In fact, this preference is so strong that they are much more likely to report a preliminary study that suggests a breakthrough than follow-up research that tempers the enthusiasm. 11 Unfortunately, it's very common for promising innovations to fail the test of further investigation: An Australian paper that reassessed 30 reports of breakthroughs from the Sydney Morning Herald 10 years after their publication found that only 27% of these advances had so far proven valuable enough to be incorporated into practice. 10 Although journalists may tend to report positive findings selectively, there is evidence that their scientific sources may often be the ones responsible for ''hyping'' the results of individual studies. A Canadian study of 627 newspaper accounts from the 4 most populous English-speaking countries reported that only 11% were guilty of ''moderately or highly'' exaggerating the claims of the original articles from medical journals. 1 The authors went on to conclude that, if any hype was being imparted to the research, it was indebted to the complicit collaboration of the original scientific reports, since 98% of them stressed the benefits of the described treatment but only 5% disclosed the risks or costs.
It is probably only natural that researchers want to be known as the creators of therapeutic advances; this desire can lead to a tendency to selectively emphasize the positive aspects of a study. It is the duty of journal reviewers and editors to rein in such oversimplification. This tendency can extend beyond researchers to practitioners. How many newspaper articles or website blurbs have you seen that tout an orthopaedic sports medicine specialist as offering a groundbreaking treatment that is unproven or risky, or simply widely available? Since there is considerable evidence that the public's understanding and behavior on health issues is influenced by what they hear and read, 2, 3, 7, 9, 15 it is important for authors, practitioners, and those who publicize their work to help disseminate the balanced truth about the cutting edge, even if it's a bit duller than we'd like it to be.
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